Western Australian medical technology company OncoRes Medical has been nominated for the 2026 Prix Galien USA Awards in the Best Startup category. The nomination recognises the company’s work in helping surgeons to identify microscopic cancer tissue in real time.
The Prix Galien Awards are among the world’s most prestigious honours for innovation in life sciences and healthcare. They are often considered by the research community as the equivalent of the Nobel Prize in health and medical innovation.
The nomination highlights the international significance of OncoRes Medical’s technology, and its potential to improve outcomes for people undergoing cancer surgery.